Home
> Archives
Archived Child Content
Archived Guidelines
- 2014 Neurodevelopmental Disorders: Psychotropic Medication Recommendations for Target Symptoms in Youth - Full Set of Guidelines
- 2014-2015 ADHD Medication Guidelines for Children and Adolescents
- 2014-2015 Aggression Medication Guidelines for Children and Adolescents
- 2014-2015 Anxiety Disorders Medication Guidelines for Children and Adolescents
- 2014-2015 Bipolar Disorders Medication Guidelines for Children and Adolescents
- 2014-2015 Insomnia Disorder Medication Guidelines for Children and Adolescents
- 2014-2015 Major Depression Medication Guidelines for Children and Adolescents
- 2014-2015 Obsessive-Compulsive Disorder Medication Guidelines for Children and Adolescents
- 2014-2015 PTSD Medication Guidelines for Children and Adolescents
- 2014-2015 Schizophrenia (Early Onset) Medication Guidelines for Children and Adolescents
- 2014-2015 Tic Disorders Medication Guideliens for Children and Adolescents
- 2014-2015 Principles of Practice Regarding the Use of Psychotropic Medication in Children Under Age 6
- 2014-2015 Florida Psychotherapeutic Medication Guidelines for Children and Adolescents - Full Set of Guidelines
- 2016 Antipsychotic High Dosing Table for Children and Adolescents
- 2012 Florida Best Practice Medication Child and Adolescent Guidelines
- 2015 Autism Spectrum Disorder & Intellectual Disability Disorder: Florida Best Practice Psychotherapeutic Medication Recommendations for Target Symptoms - Full Set of Guidelines
- 2015 Treatment of Hyperactive, Impulsive, and Inattentive Symptoms in the Context of ASD & ID
- 2015 Principles of Practice Regarding Psychotropic Treatment in the Context of ASD & ID
- 2015 Treatment of Anxiety in the Context of ASD & ID
- 2015 Treatment of Aggression in the Context of ASD & ID
- 2015 Treatment of Sleep Disturbances in the Context of ASD & ID
- 2015 Treatment of Restricted, Repetitive Behaviors in the Context of ASD & ID
- 2015 Treatment of Depression or Bipolar Disorder Symptoms in the Context of ASD & ID
- 2015 Treatment with Psychotropic Medications in the Context of ASD & ID
- *2016 - 2017 Florida Best Practice Psychotherapeutic Medication Guidelines for Children and Adolescents - Full Set of Guidelines
- *2016 - 2017 Principles of Practice Regarding the Use of Psychotropic Medication in Children Under Age 6
- *2016 - 2017 Principles of Practice Regarding the Use of Psychotropic Medication in Children and Adolescents 6 to 17 Years Old
- 2016 - 2017 ADHD Medication Guidelines for Children and Adolescents
- 2016 - 2017 Aggression Medication Guidelines for Children and Adolescents
- 2016 - 2017 Anxiety Medication Guidelines for Children and Adolescents
- 2016 - 2017 Bipolar Disorders Medication Guidelines for Children and Adolescents
- 2016 - 2017 Insomnia Disorder Medication Guidelines for Children and Adolescents
- 2016 - 2017 Major Depression Medication Guidelines for Children and Adolescents
- 2016 - 2017 Obsessive-Compulsive Disorder Medication Guidelines for Children and Adolescents
- 2016 - 2017 Tic Disorders Medication Guidelines for Children and Adolescents
- 2016 - 2017 PTSD Medication Guidelines for Children and Adolescents
- 2016 - 2017 Schizophrenia (Early Onset) Medication Guidelines for Children and Adolescents
- 2016 - 2017 Recommendations on DMDD in Children and Adolescents
- 2016 - 2017 Monitoring Side-Effects of Antipsychotic Medication in Children and Adolescents
- 2017 Autism Spectrum Disorder & Intellectual Developmental Disorder: Florida Best Practice Psychotherapeutic Medication Recommendations for Target Symptoms - Full Set of Guidelines
- 2017 Principles of Practice in the Context of ASD & ID
- 2017 Principles of Practice in the Context of ASD & ID - Under 6 Years Old
- 2017 Principles of Practice in the Context of ASD & ID - 6 to 17 Years Old
- 2017 Side Effects Monitoring of Antipsychotic Medication in Children and Adolescents
- 2017 Use of Psychotherapeutic Medications and Routine Monitoring in the Context of ASD & ID
- 2017 Treatment of Hyperactive, Impulsive, and Inattentive Symptoms in the Context of ASD & ID
- 2017 Treatment of Anxiety in the Context of ASD & ID
- 2017 Treatment of Aggression in the Context of ASD & ID
- 2017 Treatment of Sleep Disturbances in the Context of ASD & ID
- 2017 Treatment of Restricted, Repetitive Behaviors in the Context of ASD & ID
- 2017 Treatment of Depression or Bipolar Disorder in the Context of ASD & ID
- 2017 Treatment of Catatonia in the Context of ASD & ID
- 2017 Treatment of Psychosis in the Context of ASD & ID
Archived Summaries
- 2012 Summary of the Management of PTSD in Children and Adolescents
- 2012 Summary on the Treatment of Anxiety Disorders in Children and Adolescents
Archived Videos
- 2012 Expert Panel Meeting for Child Guidelines - Update on the Evidence Based Treatment of Major Depressive Disorder Under 17
- 2012 Expert Panel Meeting - ADHD Guideline Update for Children and Adolescents
- 2012 Expert Panel Meeting for Child Guidelines - Anxiety Disorders Treatment Guidelines Updates - Part 1
- 2012 Expert Panel Meeting for Child Guidelines - Update on the Evidence Based Treatment Manic or Mixed Episodes of Bipolar 1 Disorder Under 17
- 2012 Expert Panel Meeting for Child Guidelines - Update on the Evidence Based Treatment of Chronic Impulsive Aggression Under 17
- 2012 Expert Panel Meeting for Child Guideline - Treatment of PTSD in Children & Adolescents
- 2009 Expert Panel Meeting Dually Diagnosed Children - Pharmacotherapy of Tics, Tourette's and Psychiatric Comorbidity/ Developmental Disorders
- 2011 SIPP Meeting - The SIPP Process: A Community Provider Perspective
- Archive - Intro to Increase Evidence Based Prescribing
- 2010 Expert Panel Meeting for Child Guidelines - On the Road to DSM 5 Present Status
- Archive - Quality Improvement for Psychotherapeutic Prescribing - Background and History
- Archive - Quality Improvement for Psychotherapeutic Prescribing - Diagnostic Challenges in ADHD: Differentiating ADHD from Pediatric Bipolar Disorder
- 2012 Expert Panel Meeting for Child Guidelines - Psychopharmacologic Treatment of Complicated Anxiety Disorders in Youth
- 2010 Psychopharmacologic Treatment of Aggression in Psychiatric and Developmental Disorders: Update of MDTMP Treatment Guidelines
- Archive - Children and Adolescent Mental Health Professionals
- 2011 SIPP Meeting - Evidence-Based Psychosocial Practices for Child Inpatient Psychiatric Care
- 2010 Expert Panel Meeting for Children - Aggressive & Self-Injurious Behaviors in Children & Adolescents with Developmental Disabilities
- Archive - New Approaches to Managing Impulsive Aggression in Children and Adolescents
- 2010 Expert Panel Meeting for Child Guidlines - Pediatric ADHD Psychopharmacology: New Developments and Treatment of Comorbid Aggression
- 2008 Preschool Anxiety Disorders: From Epidemiology to Neural Substrates to Clinical Practice
- 2010 Expert Panel Meeting for Child Guidelines - Rage, Meltdowns & Aggression in Tics and OCD
- 2009 Psychopharmacology in PDD: What We Know and What We Don't Know
- Archive - Using Psychotropic Medications Among Youth: Public Policy Considerations (Part 2)
- 2012 Expert Panel Meeting for Child Guidelines - Anxiety Disorders Treatment Guidelines Updates - Part 2
- Schizophrenia (Early-Onset) Treatment Guidelines - Expert Panel Meeting - 2014
- ADHD Treatment Guidelines Update - Expert Panel Meeting - 2014 Part 1
- Chronic Impulsive Aggression Treatment Guidelines Update - Expert Panel Meeting - 2014
- Insomnia Disorder Treatment Guidelines - Expert Panel Meeting - 2014
- OCD and Tic Treatment Guidelines - Expert Panel Meeting - 2014
- PTSD Treatment Guidelines Update - Expert Panel Meeting - 2014
- Bipolar Disorders Treatment Guideline Updates - Expert Panel Meeting - 2014
- Sleep Disturbances Treatment in the Context of ASD & ID - Castellanos (2015)
- Aggression Treatment in the Context of ASD & ID - Tandon (2015)
- Comorbid Mania/Hypomania & Psychosis in the Context of ASD & ID - Tandon (2015)
- Attention-Deficit/Hyperactive Behaviors, Anxiety, Depression, and Repetitive Patterns of Behavior Treatment in the Context of ASD & ID - Veenstra-VanderWeele (2015)
- Adolescent ADHD and Mental Health: Theory and Practice in Primary Care
- 2016 Expert Panel Meeting for Monitoring Physical Health & Side Effects - Psychotherapeutic Medication Use in Special Populations: Children (Sahasranaman)
- 2016 Expert Panel Meeting for Children and Adolescent Guidelines - ADHD (Bussing)
- 2016 Expert Panel Meeting for Children and Adolescent Guidelines - Aggression (Wojas)
- 2016 Expert Panel Meeting for Children and Adolescent Guidelines - Bipolar Disorder (Carlson)
- 2016 Expert Panel Meeting for Children and Adolescent Guidelines - DMDD (Carlson)
- 2016 Expert Panel Meeting for Children and Adolescent Guidelines - Insomnia Disorder & Major Depression (Castellanos)
- 2016 Expert Panel Meeting for Children and Adolescent Guidelines - OCD and Tic Disorder (Murphy)
- 2016 Expert Panel Meeting for Children and Adolescent Guidelines - PTSD (Keeshin)
- 2016 Expert Panel Meeting for Children and Adolescent Guidelines - Schizophrenia (early onset) (McClellan)
- 2016 Expert Panel Meeting for Children and Adolescent Guidelines - Non-OCD Anxiety (Stock)
- 2017 Expert Panel Meeting for ASD & ID Guidelines - ADHD (Politte)
- 2017 Expert Panel Meeting for ASD & ID Guidelines - Anxiety (Politte)
- 2017 Expert Panel Meeting for ASD & ID Guidelines - Aggressive Behavior (Politte)
- 2017 Expert Panel Meeting for ASD & ID Guidelines - Sleep Disturbances (Castellanos)
- 2017 Expert Panel Meeting for ASD & ID Guidelines - Depression & Mania (Politte)
- 2017 Expert Panel Meeting for ASD & ID Guidelines - Psychosis & Catatonia (Politte)
- 2017 Expert Panel Meeting for ASD & ID Guidelines - Restricted, Repetitive Behaviors (Politte)
- 2017 Expert Panel Meeting for ASD & ID Guidelines - Medication Management (Politte)
For the highest-quality video, please view videos in the latest browser available. If you have any questions or issues, please contact Sabrina Singh.
©
2019
USF Medicaid Drug Therapy Management Program for
Behavioral
Health